Catalyst Biosciences, Inc. (CBIO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 09:51AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 56.34M |
| Enterprise Value | 23.44M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.44 |
| Price/Book (mrq) | 2.08 |
| Enterprise Value/Revenue | 3.52 |
| Enterprise Value/EBITDA | -0.29 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.90 |
| 52-Week Change 3 | -57.86% |
| S&P500 52-Week Change 3 | -12.09% |
| 52 Week High 3 | 5.2000 |
| 52 Week Low 3 | 0.3500 |
| 50-Day Moving Average 3 | 1.0054 |
| 200-Day Moving Average 3 | 1.4603 |
Share Statistics
| Avg Vol (3 month) 3 | 6.74M |
| Avg Vol (10 day) 3 | 3.41M |
| Shares Outstanding 5 | 31.48M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 22.73M |
| % Held by Insiders 1 | 25.09% |
| % Held by Institutions 1 | 31.36% |
| Shares Short (Jun 14, 2022) 4 | 1.47M |
| Short Ratio (Jun 14, 2022) 4 | 0.09 |
| Short % of Float (Jun 14, 2022) 4 | 4.72% |
| Short % of Shares Outstanding (Jun 14, 2022) 4 | 4.68% |
| Shares Short (prior month May 12, 2022) 4 | 158.35k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Feb 12, 2017 |
| Ex-Dividend Date 4 | Aug 19, 2015 |
| Last Split Factor 2 | 1:15 |
| Last Split Date 3 | Feb 12, 2017 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2021 |
| Most Recent Quarter (mrq) | Mar 30, 2022 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -1,125.12% |
Management Effectiveness
| Return on Assets (ttm) | -58.82% |
| Return on Equity (ttm) | -122.02% |
Income Statement
| Revenue (ttm) | 6.67M |
| Revenue Per Share (ttm) | 0.21 |
| Quarterly Revenue Growth (yoy) | -45.90% |
| Gross Profit (ttm) | -64.91M |
| EBITDA | -74.63M |
| Net Income Avi to Common (ttm) | -80.03M |
| Diluted EPS (ttm) | -2.5480 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 34.82M |
| Total Cash Per Share (mrq) | 1.11 |
| Total Debt (mrq) | 1.91M |
| Total Debt/Equity (mrq) | 7.05 |
| Current Ratio (mrq) | 2.78 |
| Book Value Per Share (mrq) | 0.86 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -71.45M |
| Levered Free Cash Flow (ttm) | -39.04M |
© 2022 Yahoo. All rights reserved.
